kynostatin 272 has been researched along with urea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freedberg, DI; Kaufman, JD; Kiso, Y; Stahl, SJ; Torchia, DA; Wang, YX; Wingfield, PT; Yamazaki, T | 1 |
| Antosiewicz, J; Geller, M; Gilson, MK; Head, MS; Hodge, CN; Klabe, RM; Trylska, J | 1 |
| Gold, D; Loftus, R | 1 |
3 other study(ies) available for kynostatin 272 and urea
| Article | Year |
|---|---|
Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.
Topics: Amino Acid Sequence; Aspartic Acid; Azepines; Binding Sites; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Kinetics; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Oligopeptides; Point Mutation; Protein Conformation; Recombinant Proteins; Urea | 1996 |
Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease.
Topics: HIV Protease Inhibitors; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Oligopeptides; Protons; Thermodynamics; Urea | 1999 |
Protease inhibitors: where are they now?
Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine | 1995 |